Cargando…
Circulating fibrocytes are not disease-specific prognosticators in idiopathic pulmonary fibrosis
In people with idiopathic pulmonary fibrosis, circulating fibrocytes ≥2.2% were associated with a greater risk of mortality over a median 3 years of follow-up, but were not associated with disease-related decline in lung function or short-term progression. https://bit.ly/3bWydwQ
Autores principales: | Stewart, Iain D., Nanji, Henry, Figueredo, Grazziela, Fahy, William A., Maher, Toby M., Ask, Antje J., Maharaj, Shyam, Ask, Kjetil, Kolb, Martin, Jenkins, Gisli R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295504/ https://www.ncbi.nlm.nih.gov/pubmed/33766945 http://dx.doi.org/10.1183/13993003.00172-2021 |
Ejemplares similares
-
Rapid detection of circulating fibrocytes by flowcytometry in idiopathic pulmonary fibrosis
por: Alhamad, Esam H., et al.
Publicado: (2015) -
Longitudinal prediction of outcome in idiopathic pulmonary fibrosis using automated CT analysis
por: Jacob, Joseph, et al.
Publicado: (2019) -
Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis
por: van Manen, Mirjam J.G., et al.
Publicado: (2017) -
Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis
por: Kreuter, Michael, et al.
Publicado: (2019) -
Effect of pirfenidone on breathlessness in patients with idiopathic pulmonary fibrosis
por: Glassberg, Marilyn K., et al.
Publicado: (2019)